BLSM Award Disclosure
Li Yishan · SEC Form 4 · Filed Aug 10, 2026
Award
Calculated transaction value
$0
Li Yishan Executive Chairman
BLSM
Transaction date
Aug 6, 2026
Public filing date
Aug 10, 2026
Filing lag
Filed 4 days later
BLSM daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Employee Stock Option (Right to Buy) on Common Stock
- Quantity / price
- 112,701 shares @ $0
- SEC ownership
- Direct
- Transaction code
- A
- Form
- 4
- Filing identifier
- 0001772233-26-000005
Filing cohort
Transactions in this filing
Showing 7 of 7
Trades
7
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Blossomhill Therapeutics, Inc. BLSM | Conversion | Aug 10, 2026 | Not reported |
| Blossomhill Therapeutics, Inc. BLSM | Conversion | Aug 10, 2026 | Not reported |
| Blossomhill Therapeutics, Inc. BLSM | Conversion | Aug 10, 2026 | Not reported |
| Blossomhill Therapeutics, Inc. BLSM | Conversion | Aug 10, 2026 | Not reported |
| Blossomhill Therapeutics, Inc. BLSM | Conversion | Aug 10, 2026 | Not reported |
| Blossomhill Therapeutics, Inc. BLSM | Conversion | Aug 10, 2026 | Not reported |
| Blossomhill Therapeutics, Inc. BLSM Current | Award | Aug 6, 2026 | $0 |